Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Calcagno

Showing results (31-40 of 258) with videos related to

Pageof 26
Sort By:
AIDS (London, England)|December 3, 2019
What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?Sarah B Joseph, Mattia Trunfio, Laura P Kincer, et al.
BMC Veterinary Research|October 2, 2025
A one-health approach to surveillance of tick-borne pathogens across different host groupsRachele Vada, Stefania Zanet, Anna Trisciuoglio, et al.
Microorganisms|September 28, 2024
Central Nervous System Disorders with Auto-Antibodies in People Living with HIVGiacomo Stroffolini, Cristiana Atzori, Daniele Imperiale, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 10, 2025
Which trial do we need? Combination regimen for individuals exposed to multidrug-resistant Mycobacterium tuberculosisDivya Shah, Giovanni Fumagalli, Niccolo Riccardi, et al.
Microorganisms|July 27, 2022
Concurrent and Subsequent Co-Infections of <i>Clostridioides difficile</i> Colitis in the Era of Gut Microbiota and Expanding Treatment OptionsMattia Trunfio, Silvia Scabini, Walter Rugge, et al.
AIDS Research and Human Retroviruses|July 8, 2014
Disappearance of renal stones in an HIV-1-infected patient after reduction of atazanavir doseMassimiliano Lanzafame, Stefano Bonora, Emanuela Lattuada, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2013
Elimination half-life may explain the relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1Andrea Calcagno, Lucio Boglione, Francesco Giuseppe De Rosa, et al.
AIDS (London, England)|March 18, 2010
Raltegravir penetration in the cerebrospinal fluid of HIV-positive patientsAndrea Calcagno, Stefano Bonora, Roberto Bertucci, et al.
Le Infezioni in Medicina|December 25, 2015
A probable drug-to-drug interaction between voriconazole and haloperidol in a CYP2C19 poor metabolizing patient. [corrected]Ilaria Motta, Andrea Calcagno, Lorena Baietto, et al.
Antiviral Therapy|February 10, 2016
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosisAlice Trentalange, Andrea Calcagno, Valeria Ghisetti, et al.
Pageof 26

Showing results (31-40 of 258) with videos related to

Sort By:
Pageof 26
AIDS (London, England)|December 3, 2019
What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?Sarah B Joseph, Mattia Trunfio, Laura P Kincer, et al.
BMC Veterinary Research|October 2, 2025
A one-health approach to surveillance of tick-borne pathogens across different host groupsRachele Vada, Stefania Zanet, Anna Trisciuoglio, et al.
Microorganisms|September 28, 2024
Central Nervous System Disorders with Auto-Antibodies in People Living with HIVGiacomo Stroffolini, Cristiana Atzori, Daniele Imperiale, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 10, 2025
Which trial do we need? Combination regimen for individuals exposed to multidrug-resistant Mycobacterium tuberculosisDivya Shah, Giovanni Fumagalli, Niccolo Riccardi, et al.
Microorganisms|July 27, 2022
Concurrent and Subsequent Co-Infections of <i>Clostridioides difficile</i> Colitis in the Era of Gut Microbiota and Expanding Treatment OptionsMattia Trunfio, Silvia Scabini, Walter Rugge, et al.
AIDS Research and Human Retroviruses|July 8, 2014
Disappearance of renal stones in an HIV-1-infected patient after reduction of atazanavir doseMassimiliano Lanzafame, Stefano Bonora, Emanuela Lattuada, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2013
Elimination half-life may explain the relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1Andrea Calcagno, Lucio Boglione, Francesco Giuseppe De Rosa, et al.
AIDS (London, England)|March 18, 2010
Raltegravir penetration in the cerebrospinal fluid of HIV-positive patientsAndrea Calcagno, Stefano Bonora, Roberto Bertucci, et al.
Le Infezioni in Medicina|December 25, 2015
A probable drug-to-drug interaction between voriconazole and haloperidol in a CYP2C19 poor metabolizing patient. [corrected]Ilaria Motta, Andrea Calcagno, Lorena Baietto, et al.
Antiviral Therapy|February 10, 2016
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosisAlice Trentalange, Andrea Calcagno, Valeria Ghisetti, et al.
Pageof 26